SCHEMBL30005652

SCHEMBL30005652

Cc1c(Br)cc(F)c2c1-n1c(C)nnc1C(C)(C)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21624323 1.00 — —
SCHEMBL30006224 0.86 — —
SCHEMBL21624306 0.86 — —
SCHEMBL21624311 0.85 CYP11B1 (0.33) —
SCHEMBL30005469 0.85 MEN1 (0.33) —
SCHEMBL21624293 0.85 MEN1 (0.33) —
SCHEMBL30668458 0.85 — —
SCHEMBL21624391 0.85 — —
SCHEMBL21624359 0.85 — —
SCHEMBL30005792 0.85 CYP11B1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112771046-B Other substituted triazoloquinoxaline derivatives 格吕伦塔尔有限公司 2023-09-19 — — CN disclosed
US-20220396578-A1 QUINOXALINE DERIVATIVES GRUENENTHAL GMBH (DE) 2022-12-15 — — US disclosed
EP-4090660-A1 QUINOXALINE DERIVATIVES Grünenthal GmbH (DE) 2022-11-23 — — EP disclosed
Send feedback